VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
UHTUniversal Health Realty Income Trust
$42.89$595M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksUHTFinancials

Universal Health Realty Income Trust (UHT) Financials

30Y historyFree accessUpdated daily

Revenue growth has effectively stalled at 0.18% year-over-year, though the trust maintains structural efficiency with a robust NOI margin of 70.6% as of 2026Q1.

UHT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue148.66M99.19M99.01M95.58M90.63M84.19M78.01M77.16M76.21M72.35M67.08M63.95M59.79M54.28M53.95M29.49M28.88M31.91M29.18M27.96M31.71M32.59M31.01M26.31M27.17M26.31M26.05M23.86M23.23M23.1M21.92M
Revenue Growth %51.05%0.18%3.6%5.46%7.64%7.92%1.1%1.25%5.34%7.85%4.9%6.96%10.14%0.61%82.92%2.13%-9.51%9.35%4.38%-11.84%-2.69%5.08%17.89%-3.17%3.25%0.99%9.17%2.72%0.58%5.37%7.38%
Property Operating Expenses14.14M5.59M5.48M5.32M5.1M4.41M4.14M3.97M3.81M3.58M3.26M2.81M2.54M2.37M2.12M2.01M1.85M00000000000000
Net Operating Income (NOI)134.52M93.59M93.53M90.25M85.53M79.78M73.87M73.19M72.4M68.77M63.82M61.14M57.24M51.91M51.83M27.49M27.03M31.91M29.18M27.96M31.71M32.59M31.01M26.31M27.17M26.31M26.05M23.86M23.23M23.1M21.92M
NOI Margin %90.49%94.36%94.46%94.43%94.38%94.77%94.69%94.85%95.01%95.06%95.14%95.61%95.74%95.64%96.07%93.19%93.59%100%100%100%100%100%100%100%100%100%100%100%100%100%100%
Operating Expenses80.64M58.83M56.73M58.9M54.86M50.92M47.87M47.44M45.7M44.73M41.7M40.5M38.19M33.37M35.47M18.76M11.72M13.98M17.19M11.12M13.01M13.25M10.91M7.37M8.06M7.7M7.35M8.44M6.94M6.63M5.83M
G&A Expenses1.4M000004.14M3.97M3.81M3.58M3.26M2.81M2.54M2.37M2.12M2.53M1.85M1.61M1.57M1.43M00000000000
EBITDA82.86M63.62M64.22M59.08M57.22M56.34M51.59M51.62M51.68M49.15M45.12M42.84M40.02M37.39M36.58M16.03M21.59M24.33M17.9M22.05M24.27M24.96M25.41M23.47M23.53M23.02M23.16M19.28M20.17M20.24M19.73M
EBITDA Margin %55.73%64.14%64.86%61.82%63.14%66.92%66.13%66.9%67.81%67.94%67.26%66.98%66.94%68.88%67.8%54.36%74.75%76.24%61.32%78.87%76.51%76.58%81.95%89.23%86.62%87.48%88.9%80.78%86.81%87.62%90%
Depreciation & Amortization28.97M28.86M27.42M27.73M26.56M27.48M25.58M25.87M24.98M25.12M23.01M22.2M20.98M18.84M20.22M7.31M6.29M6.4M5.9M5.21M5.56M5.62M5.31M4.54M4.43M4.4M4.46M3.86M3.88M3.77M3.64M
D&A / Revenue %19.49%29.09%27.69%29.02%29.3%32.64%32.79%33.53%32.77%34.72%34.3%34.71%35.08%34.71%37.47%24.77%21.77%20.05%20.23%18.63%17.53%17.25%17.13%17.24%16.31%16.73%17.12%16.16%16.7%16.34%16.59%
Operating Income53.89M34.76M36.8M31.35M30.67M28.86M26M25.75M26.7M24.04M22.11M20.64M19.05M18.55M16.36M8.73M15.3M17.93M11.99M16.84M18.7M19.34M20.1M18.94M19.1M18.62M18.7M15.42M16.29M16.46M16.09M
Operating Margin %36.25%35.05%37.16%32.8%33.84%34.29%33.33%33.37%35.04%33.22%32.97%32.27%31.86%34.17%30.32%29.59%52.98%56.19%41.09%60.24%58.98%59.33%64.82%71.99%70.31%70.76%71.78%64.62%70.11%71.28%73.41%
Interest Expense4M21.87M23.83M22.03M10.76M8.81M8.26M10.53M9.67M10.06M9.36M8.22M8.38M7.47M7.77M2.4M1.94M2.45M2.39M1.75M2.28M3.3M3.36M2.5M2.4M3.9M6.11M03.49M02.56M
Interest Coverage-1.77x1.81x1.70x2.96x13.39x3.35x2.80x3.50x5.53x2.84x3.88x7.15x2.76x3.51x31.72x9.41x7.33x6.93x9.63x8.19x5.86x9.24x10.54x14.98x6.75x4.26x-4.67x-6.70x
Non-Operating Income18.23M-3.96M-6.27M-6.08M-1.19M-89.11M-1.71M-3.75M-7.16M-31.64M-4.46M-11.28M-40.88M-2.1M-10.88M-67.47M-2.95M0-4.58M000-10.91M-7.37M-16.91M-7.7M-7.35M00-12.94M-1.1M
Pretax Income17.85M17.61M19.23M15.4M21.1M109.17M19.45M18.96M24.2M45.62M17.21M23.69M51.55M13.17M19.48M73.79M16.31M18.58M11.65M16.84M18.7M19.34M20.1M18.94M19.1M18.62M18.7M15.42M16.29M16.46M16.09M
Pretax Margin %12.01%17.75%19.43%16.11%23.28%129.67%24.93%24.58%31.75%63.05%25.66%37.05%86.23%24.26%36.1%250.2%56.48%58.21%39.93%60.24%58.98%59.33%64.82%71.99%70.31%70.76%71.78%64.62%70.11%71.28%73.41%
Income Tax0000000000000000000-2.82M-15.72M-5.79M-1.32M-4.2M-1.53M1.26M3.44M1.45M1.99M2.46M1.94M
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%-16.74%-84.06%-29.97%-6.58%-22.17%-8%6.77%18.38%9.4%12.22%14.97%12.03%
Net Income17.85M17.61M19.23M15.4M21.1M109.17M19.45M18.96M24.2M45.62M17.21M23.69M51.55M13.17M19.48M73.79M16.31M18.58M11.65M22.19M34.7M25.42M23.67M24.43M21.62M18.35M16.26M13.97M14.34M14M14.16M
Net Margin %12.01%17.75%19.43%16.11%23.28%129.67%24.93%24.58%31.75%63.05%25.66%37.05%86.23%24.26%36.1%250.2%56.48%58.21%39.93%79.37%109.41%78.01%76.33%92.85%79.59%69.73%62.39%58.55%61.71%60.61%64.58%
Net Income Growth %-4.6%-8.45%24.9%-27.02%-80.67%461.35%2.55%-21.62%-46.96%165%-27.34%-54.04%291.46%-32.39%-73.61%352.45%-12.2%59.41%-47.49%-36.04%36.48%7.4%-3.09%12.96%17.84%12.88%16.35%-2.55%2.41%-1.12%4.23%
Funds From Operations (FFO)46.82M46.47M46.66M43.13M47.66M136.64M45.03M44.83M49.17M70.73M40.22M45.89M72.53M32.01M39.69M81.1M22.6M24.98M17.56M27.4M40.26M31.05M28.98M28.96M26.05M22.75M20.72M17.83M18.22M17.77M17.79M
FFO Margin %31.49%46.85%47.12%45.13%52.59%162.3%57.72%58.1%64.52%97.77%59.96%71.76%121.31%58.98%73.57%274.97%78.25%78.26%60.16%98%126.94%95.26%93.45%110.09%95.9%86.46%79.52%74.71%78.4%76.95%81.17%
FFO Growth %6.23%-0.4%8.17%-9.5%-65.12%203.46%0.43%-8.82%-30.48%75.86%-12.35%-36.73%126.56%-19.35%-51.06%258.91%-9.53%42.25%-35.92%-31.94%29.67%7.12%0.08%11.16%14.52%9.81%16.2%-2.12%2.48%-0.11%4.88%
FFO per Share3.373.353.373.123.459.923.273.263.585.192.993.455.612.523.136.411.842.101.482.313.392.622.452.462.222.162.301.992.031.981.99
FFO Payout Ratio %87.96%88.29%86.58%92.19%82.2%28.2%84.33%83.44%74.9%50.97%87.36%74.29%45.11%99.18%78.59%37.86%132.17%113.74%158%99.26%66.15%82.42%81.04%79.28%86.13%90.47%79.78%90.95%86.28%85.87%85.28%
EPS (Diluted)1.291.271.391.111.537.921.411.381.763.351.281.783.991.041.545.831.331.560.981.872.922.152.002.071.841.741.811.561.601.561.58
EPS Growth %-4.44%-8.63%25.23%-27.45%-80.68%461.7%2.17%-21.59%-47.46%161.72%-28.09%-55.39%283.65%-32.47%-73.58%338.35%-14.74%59.18%-47.59%-35.96%35.81%7.5%-3.38%12.5%5.75%-3.87%16.03%-2.5%2.56%-1.27%3.95%
EPS (Basic)-1.271.391.121.537.941.421.381.763.351.281.783.991.041.545.841.331.560.981.872.942.162.022.091.851.751.811.561.601.561.58
Diluted Shares Outstanding13.88M13.86M13.84M13.81M13.79M13.78M13.77M13.75M13.72M13.63M13.47M13.3M12.93M12.7M12.67M12.65M12.26M11.9M11.88M11.88M11.87M11.84M11.81M11.78M11.75M10.54M9M8.98M8.97M8.97M8.96M

Key Metrics

Growth RegimeStable
ProfitabilityStrong
Balance SheetFortress
Cash FlowStable
Top Statement Risk

Sponsor-Linked Concentration Risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Stagnant Revenue Amid Portfolio Maturity

As reported in recent financial filings, UHT's revenue growth has effectively stalled at 0.18% year-over-year, indicating that the trust is currently in a defensive harvest phase rather than an active expansion cycle, likely constrained by the lack of accretive acquisition opportunities in the current interest rate environment.

The minimal revenue movement suggests that the trust is relying heavily on existing lease escalators rather than new property development or acquisitions. This lack of top-line momentum warrants investigation into whether the current portfolio is reaching a saturation point or if the sponsor-linked pipeline is currently yielding fewer viable investment opportunities.

Property Level Profitability Remains Resilient

According to the provided quarterly data, UHT consistently maintains a robust NOI margin near 94.4%, reflecting the structural efficiency of its triple-net lease portfolio where tenants bear the primary burden of property-level operating expenses, insurance, and tax obligations, thereby insulating the trust from inflationary cost pressures.

The sharp contraction in margin observed in 2026Q1 to 70.6% appears to be an outlier that warrants further investigation into potential non-recurring operating expenses or shifts in lease structures. Investors should monitor whether this compression represents a permanent change in the cost-sharing model or merely a temporary accounting anomaly.

FFO Stability Masks Growth Limitations

Based on the reported figures, FFO per share has fluctuated within a narrow range, with the most recent 2026Q1 result of $0.86 per share demonstrating a 3.0% growth rate, which suggests that while the dividend remains supported, the trust lacks the catalysts for meaningful earnings per share expansion.

The reliance on FFO as the primary performance metric is appropriate given the significant depreciation charges inherent in the trust's real estate assets. However, the lack of consistent FFO growth suggests that the current capital allocation strategy may be prioritizing dividend safety over the pursuit of higher-yielding, growth-oriented healthcare assets.

GAAP Distortions Obscure Economic Reality

As indicated by the disparity between GAAP net income of $5.0M and FFO of $12.0M in 2026Q1, the trust's reported earnings are heavily impacted by non-cash depreciation charges, which significantly understate the actual cash-generating capacity of the underlying healthcare facility portfolio.

Investors should be cautious when evaluating the trust based on GAAP net income, as the depreciation of medical facilities often bears little relation to the actual economic value or maintenance requirements of the assets. The recurring nature of these charges necessitates a focus on FFO to understand the true operational performance of the trust.

UHT — Frequently Asked Questions

Quick answers to the most common questions about buying UHT stock.

What was Universal Health Realty Income Trust's (UHT) revenue in 2025?

For fiscal year 2025, Universal Health Realty Income Trust (UHT) reported total revenue of $99.2M. This represents a 352.4% increase compared to $21.9M in 1996.

Is Universal Health Realty Income Trust (UHT) profitable?

Universal Health Realty Income Trust (UHT) is profitable, generating $17.6M in net income for the fiscal year ending 2025 with a net profit margin of 17.8%.

What is Universal Health Realty Income Trust's operating profit margin?

Universal Health Realty Income Trust (UHT) reported an operating income of $34.8M, resulting in an operating profit margin of 35.0%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Universal Health Realty Income Trust's gross profit and gross margin?

Universal Health Realty Income Trust (UHT) generated $93.6M in gross profit for the year, representing a gross profit margin of 94.4%. This demonstrates the company's core pricing power and production efficiency.